Refine by MP, party, committee, province, or result type.
Industry committee Absolutely. I think privacy is always a very sensitive topic, and we're more careful because we know the risks relate to consequences that he can't necessarily take back. It also sets precedent for the future. When we look at what we've done, the world has moved very conservat
June 5th, 2020Committee meeting
Fanny Sie
Industry committee Yes. I would say that the data science coalition is actually a unique view into the future. We decided to go 10 years into the future because all of a sudden, all of these multi-industry organizations, whether they were start-ups or multinationals, decided that we're all one comp
June 5th, 2020Committee meeting
Fanny Sie
Industry committee When we think about open data, the benefit of looking at open data is to see the actual benefits of data so you can prove that it actually works. Then there's that decision: What do we compete on and what do we not compete on? I think in the future there's going to be this indust
June 5th, 2020Committee meeting
Fanny Sie
Industry committee Absolutely.
June 5th, 2020Committee meeting
Fanny Sie
Industry committee But, you know, that would work out.
June 5th, 2020Committee meeting
Fanny Sie
Industry committee You're welcome.
June 5th, 2020Committee meeting
Fanny Sie
Industry committee If I were to do a scale of one to 10, I would love to say that we were on the upper edge of that. Unfortunately, I have to be honest, so I'll say a six.
June 5th, 2020Committee meeting
Fanny Sie
Industry committee As I noted in my initial comments, I think it's important to do a combination of both. It would be nice if we could test every single person every single day, but that's not going to happen. It's like taking what we can from our capacity and then complementing it with data, and d
June 5th, 2020Committee meeting
Fanny Sie
Industry committee I completely agree with you. I think testing data is important because it gives us a pulse on who is a confirmed case versus who potentially has immunity. There's also looking at the epidemiological evidence, where you cannot particularly test it in an individual, but you can loo
June 5th, 2020Committee meeting
Fanny Sie
Industry committee This pandemic has exacerbated many existing gaps in our health care system while showing the immense value that the life sciences sector brings. Issues such as system capacity, lack of virtual care and data fragmentation across the country are igniting a pressing demand for susta
June 5th, 2020Committee meeting
Fanny Sie